Cited by 21Lipoproteins and Cardiovascular HealthInflammatory Myopathies and DermatomyositisMuscle Physiology and Disorders

Outcomes of Statin Myopathy After Statin Withdrawal

Armour, Ryan, Zhou, Lan·2013·Journal of Clinical Neuromuscular Disease

Abstract

Objective To study the outcomes of statin myopathy after statin withdrawal. Methods Sixty-nine patients with mild statin myopathy were studied by chart review. Results Mean age at presentation was 62.1 years. Forty-nine (71.0%) of the 69 patients were men. Mean duration of follow-up after statin withdrawal was 18.2 months. Muscle symptoms improved in 9 (13.0%) and completely resolved in 50 (72.5%) patients. Thirteen (18.8%)/69 patients had symptoms lingered beyond 14 months. Creatine kinase (CK) levels were elevated in 52 (75.4%)/69 patients at initial presentation and returned to normal in 11 (21.3%)/52 patients at follow-up. Symptom improvement was not influenced by the initial presence of weakness, CK elevation, or myopathic changes on electromyography or muscle biopsy. Conclusions Muscle symptoms can linger beyond 14 months, and it is difficult to predict which patients will have a prolonged recovery course. CK normalization often lags behind symptom improvement, and this should not be the only indication for muscle biopsy.

Integrity signals

Registry

Crossref · 10.1097/cnd.0b013e3182852558

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 12 · Cited by 21

Authors
Armour, R., & Zhou, L.
Affiliations
Cleveland Clinic (US)
Venue
Journal of Clinical Neuromuscular Disease
Published
2013-03
Volume
14
Issue
3
Pages
103-109
ISSN
1522-0443 (ISSN-L)
OpenAlex
W2090664262
Cited by
21
References
12
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 2
FWCI
2.63
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Neuromuscular Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Epidemiology › Inflammatory Myopathies and Dermatomyositis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
statin-induced myopathy, statin withdrawal, muscle symptoms, creatine kinase, symptom resolution, recovery time course, muscle biopsy, electromyography, prolonged recovery
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Muscular Diseases, Muscle, Skeletal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review